Intelligence · Drug directory
Pipeline & Investigational Drugs
Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
Quick answer
Pipeline & investigational drugs: NovaPharmaNews tracks 1,610 pharmaceutical drugs in this segment. Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
-
human coagulation factor ix
NONAFACT
B02BD04 -
human heterologous liver cells
HEPARESC
A16 -
ibalizumab
TROGARZO
J05AX -
igovomab
INDIMACIS 125
V09IB03 -
indinavir
CRIXIVAN
J05AE02 -
infigratinib
FEBSELTIQ
L01E -
influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted)
PANDEMRIX
J07BB02 -
influenza vaccine (h1n1)v (whole virion, vero cell derived, inactivated)
CELVAPAN
J07BB01 -
influenza vaccine (split virion, inactivated)
INTANZA
J07BB02 -
influenza vaccine h1n1v (surface antigen, inactivated, adjuvanted)
FOCETRIA
J07BB02 -
interferon alfa-2a
ALPHEON
L03AB04 -
interferon alfacon-1
INFERGEN
L03AB09 -
iodine (131i) omburtamab
OMBLASTYS
V10XA -
iron oxide
SINEREM
-
laropiprant
TREVACLYN
C10AD52 -
lasofoxifene
FABLYN
G03 -
lenadogene nolparvovec
LUMEVOQ
S01 -
leniolisib
JOENJA
-
lepirudin
REFLUDAN
B01AE02 -
leriglitazone
NEZGLYAL
A16AX23 -
levacetylmethadol
ORLAAM
N02AC -
lisuride
NENAD
-
mangafodipir
TESLASCAN
V08CA05 -
maralixibat
LIVMARLI
A05AX
Frequently asked questions
How many pipeline drugs are listed?
1,610 drug profiles match this regulatory segment in our published index.
Where does approval data come from?
Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.